Neuromedin S vs Neurotensin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Neuromedin S (NMS) is a 36-amino acid amidated neuropeptide discovered in 2005 that shares a C-terminal amino acid sequence with neuromedin U (NMU) and activates the same NMUR1 and NMUR2 receptors. However, NMS has a markedly different expression pattern: while NMU is broadly exp...
Calculate Neuromedin S dose →Neurotensin (NT) is a 13-amino acid neuropeptide widely distributed throughout the central and peripheral nervous systems, with high concentrations in the hypothalamus, nucleus accumbens, and gastrointestinal tract. Discovered in 1973, neurotensin modulates dopaminergic signaling...
Calculate Neurotensin dose →| Parameter | Neuromedin S | Neurotensin |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | Research | Research |
| Half-Life | Short (minutes, estimated) | < 5 min (plasma) |
| Typical Dose | 1-10 nmol (central, animal) | 1-10 nmol/kg (animal) |
| Frequency | Variable | Variable |
| Route | Intracerebroventricular, Subcutaneous | Subcutaneous, Intracerebroventricular |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.